Versigent (NYSE:VGNT) Now Covered by Analysts at Wells Fargo & Company

Wells Fargo & Company initiated coverage on shares of Versigent (NYSE:VGNT) in a research note issued to investors on Monday, Marketbeat.com reports. The firm issued an overweight rating and a $35.00 target price on the stock.

Separately, Royal Bank Of Canada started coverage on shares of Versigent in a report on Tuesday, March 31st. They set a “sector perform” rating and a $28.00 target price for the company. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $31.50.

Versigent Trading Up 0.5%

NYSE:VGNT opened at $28.24 on Monday. Versigent has a twelve month low of $26.52 and a twelve month high of $34.99.